Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Grever

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Journal of Natural Products|October 1, 1993
The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agentsG M Cragg, S A Schepartz, M Suffness, et al.
British Journal of Haematology|April 1, 1989
Marrow transplantation following busulfan and cyclophosphamide for chronic myelogenous leukaemia in accelerated or blastic phaseE A Copelan, M R Grever, N Kapoor, et al.
The Journal of Laboratory and Clinical Medicine|May 1, 1983
Urinary excretion of modified nucleosides in chronic myelogenous leukemiaD A Heldman, M R Grever, C E Speicher, et al.
Archives of Biochemistry and Biophysics|July 1, 1972
The interactions between biogenic amines and pyridoxal, pyridoxal phosphate, and pyridoxal kinaseJ T Neary, R L Meneely, M R Grever, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1991
Queuine, a tRNA anticodon wobble base, maintains the proliferative and pluripotent potential of HL-60 cells in the presence of the differentiating agent 6-thioguanineB T French, D E Patrick, M R Grever, et al.
American Journal of Hematology|November 1, 1991
Cardiac complications observed in elderly patients following 2'-deoxycoformycin therapyJ L Grem, S A King, H G Chun, et al.
Journal of the National Cancer Institute|August 1, 1983
Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemiaD A Heldman, M R Grever, J S Miser, et al.
Journal of Interferon Research|October 1, 1990
Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cellsP L Triozzi, K A Avery, M R Grever, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Differential effect of 6-ethylmercaptopurine on c-myc expression in wild-type and HGPRT-deficient HL-60 cellsB T French, D E Patrick, M R Grever, et al.
Seminars in Oncology|March 3, 1998
Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goalsJ C Byrd, K R Rai, E A Sausville, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Journal of Natural Products|October 1, 1993
The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agentsG M Cragg, S A Schepartz, M Suffness, et al.
British Journal of Haematology|April 1, 1989
Marrow transplantation following busulfan and cyclophosphamide for chronic myelogenous leukaemia in accelerated or blastic phaseE A Copelan, M R Grever, N Kapoor, et al.
The Journal of Laboratory and Clinical Medicine|May 1, 1983
Urinary excretion of modified nucleosides in chronic myelogenous leukemiaD A Heldman, M R Grever, C E Speicher, et al.
Archives of Biochemistry and Biophysics|July 1, 1972
The interactions between biogenic amines and pyridoxal, pyridoxal phosphate, and pyridoxal kinaseJ T Neary, R L Meneely, M R Grever, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1991
Queuine, a tRNA anticodon wobble base, maintains the proliferative and pluripotent potential of HL-60 cells in the presence of the differentiating agent 6-thioguanineB T French, D E Patrick, M R Grever, et al.
American Journal of Hematology|November 1, 1991
Cardiac complications observed in elderly patients following 2'-deoxycoformycin therapyJ L Grem, S A King, H G Chun, et al.
Journal of the National Cancer Institute|August 1, 1983
Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemiaD A Heldman, M R Grever, J S Miser, et al.
Journal of Interferon Research|October 1, 1990
Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cellsP L Triozzi, K A Avery, M R Grever, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Differential effect of 6-ethylmercaptopurine on c-myc expression in wild-type and HGPRT-deficient HL-60 cellsB T French, D E Patrick, M R Grever, et al.
Seminars in Oncology|March 3, 1998
Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goalsJ C Byrd, K R Rai, E A Sausville, et al.
Pageof 10